Medscape www.medscape.com

References for:
West Nile Virus Infection

[Am J Health-Syst Pharm 61(12):1235-1241, 2004. © 2004 American Society of Health-System Pharmacists]

  1. Campbell GL, Martin AA, Lanciotti RS et al. West Nile virus 2002. Lancet Infect Dis. 2002; 2:519-29.
  2. Laboratory safety for arboviruses and certain other viruses of vertebrates. The Subcommittee on Arbovirus Laboratory Safety of the American Committee on Arthropod-Borne Viruses. Am J Trop Med Hyg. 1980; 29:1359-81.
  3. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976; 13:105-14.
  4. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev. 1995; 8:389-405.
  5. From the Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections—United States, 2002. JAMA. 2003; 289:414-5.
  6. Roehrig JT, Layton M, Smith P et al. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol. 2002; 267:223-40.
  7. Pealer LN, Marfin AA, Petersen LR et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003; 349:1236-45.
  8. Update: detection of West Nile virus in blood donations—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003; 52:916-9. [Erratum, MMWR Morb Mortal Wkly Rep. 2003; 52:942.]
  9. Mostsahari F, Bunning ML, Kitsutani PT et al. Epidemic West Nile encephalitis, New York, 1999: results of a household based seroepidemilogical study. Lancet. 2001; 358:261-4.
  10. Sejvar J, Haddad M, Tierney B et al. Neurological manifestations and outcome of West Nile virus infection. JAMA. 2003; 290:511-5. [Erratum, JAMA. 2003; 290: 1318.]
  11. Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg Infect Dis. 2001; 7:611-4.
  12. Tsai TF, Popovici F, Cernescu C et al. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998; 352:767-71.
  13. Platonov AE, Shipulin GA, Shipulina OY et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis. 2001; 7:128-32.
  14. Chowers MY, Lang R, Nassar F et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis. 2001; 7:675-8.
  15. West Nile virus activity—United States, 2001. MMWR Morb Mortal Wkly Rep. 2002; 51:497-501.
  16. Petersen LR, Marfin AR. West Nile virus: a primer for the clinician. Ann Intern Med. 2002; 137:173-9.
  17. Nash D, Mostashari F, Fine A et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001; 344:1807-14.
  18. Outbreak of West Nile-like viral encephalitis—New York, 1999. MMWR Morb Mortal Wkly Rep. 1999; 48:845-9.
  19. Anderson JF, Andreadis TG, Vossbrinck CR et al. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science. 1999; 286:2331-3.
  20. Jia XY, Briese T, Jordan I et al. Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet. 1999; 354:1971-2.
  21. Lanciotti RS, Roehrig JT, Deubel V et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science. 1999; 286:2333-7.
  22. West Nile virus activity—United States, October 16-22, 2003. MMWR Morb Mortal Wkly Rep. 2003; 52:1022-3.
  23. Solomon T, Ooi MH, Beasley DW et al. West Nile encephalitis. BMJ. 2003; 326: 865-9.
  24. Nosal B, Pellizzari R. West Nile virus. CMAJ. 2003; 168:1443-4.
  25. Calisher CH, Karabatsos N, Dalrymple JM et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal anti-sera. J Gen Virol. 1989; 70:37-43.
  26. Burt FJ, Grobbelaar AA, Leman PA. Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis. 2002; 8:820-6.
  27. Lanciotti RS, Ebel GD, Deubel V. Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology. 2002; 298:96-105.
  28. Beasley DW, Li L, Suderman MT et al. Mouse noninvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology. 2002; 296:17-23.
  29. Turell MJ, Sardelis MR, O'Guinn ML et al. Potential vectors of West Nile virus in North America. Curr Top Microbiol Immunol. 2002; 267:241-52.
  30. Bender K, Thompson FE Jr. West Nile virus: a growing challenge. Am J Nur. 2003; 103:32-9.
  31. Intrauterine West Nile virus infection—New York, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51:1135-6.
  32. Possible West Nile virus transmission to an infant through breast-feeding—Michigan, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51:877-8.
  33. Iwamoto M, Jernigan DB, Guasch A et al. Transmission of West Nile virus from a donor to four transplant recipients. N Engl J Med. 2003; 348:2196-203.
  34. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol. 2002: 267:171-94.
  35. Lanciotti RS, Kerst AJ, Nasci RS et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a Taq-Man reverse transcriptase-PCR assay. J Clin Microbiol. 2000; 38:4066-71.
  36. Ceausu E, Erscoiu S, Calistru P et al. Clinical manifestations in the West Nile virus outbreak. Rom J Virol. 1997; 48:3-11.
  37. Pepperell C, Rau N, Krajden S et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003; 168:1399-405.
  38. Shi PY, Kauffman EB, Ren P et al. High-throughput detection of West Nile virus RNA. J Clin Microbiol. 2001; 39:1264-71.
  39. Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet. 2000; 355:1614-5. Letter.
  40. Monath TP, Arroyo J, Miller C et al. West Nile virus vaccine. Curr Drug Targets Infect Disord. 2001; 1:37-50.
  41. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis. 2002; 8:107-8. Letter.
  42. Rahal J, Anderson J, Rosenberg C et al. Effect of interferon alpha-2b on St. Louis virus meningoencephalitis: clinical and laboratory results. Paper presented at 40th meeting of the Infectious Diseases Society of America. Chicago, IL; 2002 Sep 27.
  43. Solomon T, Dung NM, Wills B et al. Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial. Lancet. 2003; 362:821-6.
  44. Hamdan A, Green P, Mendelson E et al. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis. 2002; 4:160-2.
  45. Ben-Nathan D, Lustig S, Tam G et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile Virus infection in mice. J Infect Dis. 2003; 188:5-12.
  46. U.S. Environmental Protection Agency. Mosquitoes: how to control them. www.epa.gov/pesticides/factsheets/mosquito.htm (accessed 2004 Mar 10).
  47. Centers for Disease Control and Prevention. Fight the bite: avoid mosquito bites to avoid infection. www.cdc.gov/ncidod/dvbid/westnile/prevention_info.htm (accessed 2003 Jun 24).
  48. Centers for Disease Control and Prevention. Statistics, surveillance and control: West Nile virus disease 2003 human cases by clinical syndromes as of March 3, 2004. www.cdc.gov/ncidod/dvbid/westnilesurv&controlCaseCount03_detailed.htm (accessed 2004 Mar 6).
  49. Centers for Disease Control and Prevention. Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. MMWR Morb Mortal Wkly Rep. 2004; 53:154-7.